Ampio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients
By: Colorado BioScience Association Date: 09/11/2020
- Ampion-treated patients showed improvement from severe disease/hospitalization to uninfected/ambulatory on the ordinal scale
- Ampion-treated patients showed greater improvement compared to patients treated with the standard of care including anti-viral therapies
- Ampion found to be safe and well-tolerated with no drug related adverse events
Find our more here.
Categories: Ecosystem News